InMed Pharmaceuticals Inc. financial data

Symbol
INM on Nasdaq
Location
1445 885 West Georgia St., Vancouver, British Columbia, Canada
Fiscal year end
June 30
Latest financial report
Sep 23, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 464 %
Quick Ratio 59.4 %
Debt-to-equity 25.1 %
Return On Equity -93.2 % +28.7%
Return On Assets -74.5 %
Operating Margin -148 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.38M shares -82.1%
Common Stock, Shares, Outstanding 2M shares +349%
Entity Public Float 3.32M USD +41%
Common Stock, Value, Issued 91.2M USD +10.2%
Weighted Average Number of Shares Outstanding, Basic 976K shares +156%
Weighted Average Number of Shares Outstanding, Diluted 976K shares +156%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.94M USD +7.5%
Cost of Revenue 3.24M USD -7.46%
Research and Development Expense 2.85M USD -11.3%
General and Administrative Expense 6.56M USD +13.1%
Costs and Expenses -2.34M USD +37.1%
Operating Income (Loss) -6.97M USD +63.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.16M USD -6.44%
Net Income (Loss) Attributable to Parent -8.16M USD -6.34%
Earnings Per Share, Basic -8 USD/shares +58.5%
Earnings Per Share, Diluted -8 USD/shares +58.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.1M USD +68.5%
Cash, Cash Equivalents, and Short-term Investments 11.1M USD +68.2%
Accounts Receivable, after Allowance for Credit Loss, Current 465K USD +31.8%
Inventory, Net 961K USD -22.8%
Assets, Current 12.9M USD +48.1%
Property, Plant and Equipment, Net 992K USD -20.6%
Intangible Assets, Net (Excluding Goodwill) 1.62M USD -9.12%
Other Assets, Noncurrent 100K USD 0%
Assets 15.6M USD +31.8%
Accounts Payable, Current 2K USD
Employee-related Liabilities, Current 490K USD +0.44%
Accrued Liabilities, Current 85.5K USD
Liabilities, Current 1.84M USD -6.7%
Operating Lease, Liability, Noncurrent 306K USD -52.6%
Liabilities 2.15M USD -18%
Accumulated Other Comprehensive Income (Loss), Net of Tax 129K USD 0%
Retained Earnings (Accumulated Deficit) -117M USD -7.48%
Stockholders' Equity Attributable to Parent 13.4M USD +45.9%
Liabilities and Equity 15.6M USD +31.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.83M USD +16%
Net Cash Provided by (Used in) Financing Activities 838K USD
Common Stock, Shares, Issued 2M shares +349%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.1M USD +68.5%
Deferred Tax Assets, Valuation Allowance 26.8M USD +18.4%
Deferred Tax Assets, Gross 26.8M USD +18.4%
Operating Lease, Liability 741K USD -23%
Depreciation 50.2K USD +5.16%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.5M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid 788K USD -24.6%
Property, Plant and Equipment, Gross 2.33M USD -10.5%
Operating Lease, Liability, Current 436K USD +37%
Lessee, Operating Lease, Liability, to be Paid, Year Two 313K USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 475K USD +30.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 47.1K USD -42.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 219K USD -80%
Deferred Tax Assets, Operating Loss Carryforwards 5.4M USD -28%
Additional Paid in Capital 38.1M USD -0.74%
Amortization of Intangible Assets 163K USD -5.37%
Depreciation, Depletion and Amortization 54.6K USD -0.46%
Share-based Payment Arrangement, Expense 119K USD -13.4%